Orient Pharma Co., Ltd. Yunlin Plant: Drug Recall
Recall #D-0526-2025 · 06/11/2025
Class III: Low Risk
Recall Details
- Recall Number
- D-0526-2025
- Classification
- Class III
- Product Type
- Drug
- Recalling Firm
- Orient Pharma Co., Ltd. Yunlin Plant
- Status
- Ongoing
- Date Initiated
- 06/11/2025
- Location
- Yunlin County, Taiwan
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 57504 bottles
Reason for Recall
Failed Impurities/Degradation Specifications.
Product Description
Pitavastatin Tablets, 2 mg, Rx Only, 90 Tablets, Manufactured by: Orient Pharma Co., Ltd., 8 Kehu 1st Road, Huwei Chen, Yunlin, Taiwan, 63247, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054, Product of Taiwan, NDC 0480-3632-98.
Distribution Pattern
NJ
Other Recalls by Orient Pharma Co., Ltd. Yunlin Plant
- Class III: Low Risk 06/11/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.